Results 71 to 80 of about 80,831 (209)

Molecular diagnosis of Huntington disease in Portugal : implications for genetic counselling and clinical practice [PDF]

open access: yes, 2003
Huntington disease (HD) is a eurodegenerative, autosomal dominant disorder of late-onset, caused by the expansion of a CAG repeat in the coding region of the gene. Ours is the reference laboratory for genetic testing in HD, in Portugal, since 1998; 90.1%
A Durr   +39 more
core   +1 more source

Cortical and Striatal Circuits in Huntington's Disease

open access: yes, 2020
Huntington's disease (HD) is a hereditary neurodegenerative disorder that typically manifests in midlife with motor, cognitive, and/or psychiatric symptoms.
Blumenstock, S., Dudanova, I.
core   +1 more source

Corticostriatal Transmission Is Selectively Enhanced in Striatonigral Neurons with Postnatal Loss of Tsc1. [PDF]

open access: yes, 2018
mTORC1 is a central signaling hub that integrates intra- and extracellular signals to regulate a variety of cellular metabolic processes. Mutations in regulators of mTORC1 lead to neurodevelopmental disorders associated with autism, which is ...
Bateup, Helen S   +2 more
core   +2 more sources

Adult‐Onset Dystonia‐Parkinsonism: Do Not Forget SERAC1

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Giulia Scacciatella   +15 more
wiley   +1 more source

Juvenile Huntington's disease: a population-based study using the General Practice Research Database

open access: yesBMJ Open, 2013
Background The juvenile form of Huntington's disease (HD) is a rare disorder. There are no population-based estimates of either its incidence or prevalence in any population in the world.
I. Douglas   +5 more
semanticscholar   +1 more source

G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials

open access: yesMedicinal Research Reviews, Volume 45, Issue 3, Page 985-1015, May 2025.
ABSTRACT This review provides a comprehensive overview of the role of G9a/EHMT2, focusing on its structure and exploring the impact of its pharmacological and/or gene inhibition in various neurological diseases. In addition, we delve into the advancements in the design and synthesis of G9a/EHMT2 inhibitors, which hold promise not only as a treatment ...
Aina Bellver‐Sanchis   +10 more
wiley   +1 more source

Translational neurophysiology in sheep:Measuring sleep and neurological dysfunction in CLN5 affected Batten disease sheep [PDF]

open access: yes, 2015
This is the final published version of a paper originally published in BRAIN 2015: 138; 862?874, DOI: http://dx.doi.org/10.1093/brain/awv026Creating valid mouse models of slowly progressing human neurological diseases is challenging, not least because ...
Bartsch, Ullrich   +7 more
core   +2 more sources

Mitochondria‐Associated Membranes: A Key Point of Neurodegenerative Diseases

open access: yesCNS Neuroscience &Therapeutics, Volume 31, Issue 5, May 2025.
ABSTRACT Background Neurodegenerative diseases pose significant health challenges in the 21st century, with increasing morbidity and mortality, particularly among the elderly population. One of the key factors contributing to the pathogenesis of these diseases is the disrupted crosstalk between mitochondria and the endoplasmic reticulum.
Yiwei Zhang   +8 more
wiley   +1 more source

The Power Struggle: Kynurenine Pathway Enzyme Knockouts and Brain Mitochondrial Respiration

open access: yesJournal of Neurochemistry, Volume 169, Issue 5, May 2025.
Kynurenine pathway enzyme knockouts impair mitochondrial respiration. The deletion of kynurenine aminotransferase genes leads to significant impairment of mitochondrial respiration and ATP production, highlighting the critical role these enzymes play in cellular energy metabolism.
László Juhász   +17 more
wiley   +1 more source

F53 Introducing join-HD: the juvenile onset initiative for huntington’s disease [PDF]

open access: bronze, 2021
Rebecca S. Mason   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy